Prediction of multi-target networks of neuroprotective compounds with entropy indices and synthesis, assay, and theoretical study of new asymmetric 1,2-rasagiline carbamates
Por favor, use este identificador para citas ou ligazóns a este ítem:
http://hdl.handle.net/10347/22287
Ficheiros no ítem
Metadatos do ítem
Título: | Prediction of multi-target networks of neuroprotective compounds with entropy indices and synthesis, assay, and theoretical study of new asymmetric 1,2-rasagiline carbamates |
Autor/a: | Romero Durán, Francisco Javier Alonso Sousa, Nerea Caamaño Santos, María Olga García Mera, Xerardo Xusto Yañez Jato, Matilde Prado Prado, Francisco Javier González Díaz, Humberto |
Centro/Departamento: | Universidade de Santiago de Compostela. Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéutica Universidade de Santiago de Compostela. Departamento de Química Orgánica |
Palabras chave: | CHEMBL | Neuroprotective agents | Rasagiline derivatives | Asymmetric synthesis | Multi-target drugs | Molecular information measures | Shannon entropy | Markov chains | Moving averages | |
Data: | 2014 |
Editor: | MDPI |
Cita bibliográfica: | Romero Durán, F.J., Alonso, N., Caamaño Santos, M.O., García Mera, X., Yañez Jato, M., Prado Prado, J. et al. (2014). Prediction of multi-target networks of neuroprotective compounds with entropy indices and synthesis, assay, and theoretical study of new asymmetric 1,2-rasagiline carbamates. Int.J.Mol.Sci., vol. 15, 17035-17064 |
Resumo: | In a multi-target complex network, the links (Lij) represent the interactions between the drug (di) and the target (tj), characterized by different experimental measures (Ki, Km, IC50, etc.) obtained in pharmacological assays under diverse boundary conditions (cj). In this work, we handle Shannon entropy measures for developing a model encompassing a multi-target network of neuroprotective/neurotoxic compounds reported in the CHEMBL database. The model predicts correctly >8300 experimental outcomes with Accuracy, Specificity, and Sensitivity above 80%–90% on training and external validation series. Indeed, the model can calculate different outcomes for >30 experimental measures in >400 different experimental protocolsin relation with >150 molecular and cellular OPEN ACCESS Int. J. Mol. Sci. 2014, 15 17036 targets on 11 different organisms (including human). Hereafter, we reported by the first time the synthesis, characterization, and experimental assays of a new series of chiral 1,2-rasagiline carbamate derivatives not reported in previous works. The experimental tests included: (1) assay in absence of neurotoxic agents; (2) in the presence of glutamate; and (3) in the presence of H2O2. Lastly, we used the new Assessing Links with Moving Averages (ALMA)-entropy model to predict possible outcomes for the new compounds in a high number of pharmacological tests not carried out experimentally |
Versión do editor: | https://doi.org/10.3390/ijms150917035 |
URI: | http://hdl.handle.net/10347/22287 |
DOI: | 10.3390/ijms150917035 |
E-ISSN: | 1422-0067 |
Dereitos: | © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/) |
Coleccións
-
- FTF-Artigos [274]
- QO-Artigos [436]